Understanding left ventricular assist devices

التفاصيل البيبلوغرافية
العنوان: Understanding left ventricular assist devices
المؤلفون: Amer Hamdan, Melissa Gourjault, Nadia Aissaoui, Jérôme Jouan, Romain Pirracchio, Michiel Morshuis, Christian Latremouille, Benoit Diebold, Sofia Ortuno
سنة النشر: 2018
مصطلحات موضوعية: medicine.medical_specialty, Time Factors, Critical Care, medicine.medical_treatment, Population, Hemorrhage, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, Life Expectancy, 0302 clinical medicine, law, Artificial heart, medicine, Animals, Humans, ddc:610, education, Intensive care medicine, Adverse effect, Heart Failure, education.field_of_study, business.industry, Arrhythmias, Cardiac, Thrombosis, 030208 emergency & critical care medicine, Hematology, General Medicine, equipment and supplies, medicine.disease, Regimen, Nephrology, Heart failure, Ventricular assist device, Equipment Failure, Heart-Assist Devices, business, Medical literature
الوصف: Background/Aims: Long-term mechanical assist devices are now commonly used in the treatment of severe heart failure to unload the failing ventricle, maintain sufficient end-organ perfusion and improve functional capacity. Depending on the assisted ventricles, 3 categories of long-term assist devices are available: left ventricular assist device (LVAD), biventricular assist device and total artificial heart. Improvements in technology, especially the advent of smaller, durable continuous flow pumps, have led to the use of LVADs in a much broader population of patients in the last 10 years. Both the number of patients living with LVADs and the life expectancy of these patients are increasing. Regarding this growing number of patients with LVAD, intensivists need to understand the physiology of the devices, their functioning, potential complications and their management. Methods: We performed a narrative review of relevant medical literature regarding the physiology of patients with LVAD and management of common complications relevant to the critical care physicians. Results: The most frequent complications occurring in the LVAD patients after the post-operative period are bleeding, driveline infections, thrombosis, device malfunction, right ventricular failure and arrhythmias. Bleeding is the most frequent adverse event in LVAD due to a combination of anticoagulation and acquired von Willebrand disease secondary to shear stress produced within the pump. Their management includes antiplatelet therapy arrest, reduction of the anticoagulation regimen and specific therapy if feasible. Infection is the second most common cause of death after cardiac failure in LVAD patients. All infections must be aggressively treated to avoid seeding the device. Device thrombosis can develop even when patients are adequately anticoagulated and taking antiplatelet therapy because the LVAD is responsible for a chronic hypercoagulable state. Conclusion: Management of these unique patients in the ICU is best accomplished with a multidisciplinary team that includes specialists in advanced heart failure, LVAD nurse coordinators and intensivists.
وصف الملف: application/pdf
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5028d5783f579bf1ec8010cfbb8cb9ab
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/9329/AissaouiNadia.pdf
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....5028d5783f579bf1ec8010cfbb8cb9ab
قاعدة البيانات: OpenAIRE